Rhabdomyosarcoma of the vagina (sarcoma botryoides) is the most common malignant vaginal tumour in girls under 5 — it is a highly malignant soft-tissue sarcoma arising from the rhabdomyoblasts of the vaginal wall, presenting as a grape-like or polypoid mass protruding from the vaginal introitus, often associated with bloody vaginal discharge. The grape-like appearance ('botryoides' = Greek for grape) is pathognomonic. The median age at diagnosis is 2-3 years. Any vaginal mass or bleeding in a prepubertal girl is a paediatric emergency — it requires immediate 2WW referral to a paediatric oncology centre (not a general gynaecology clinic) and simultaneous safeguarding assessment (to exclude sexual abuse as a concurrent concern, since both can present with genital abnormalities). A GP should never attempt biopsy or examination under anaesthesia for a suspected vaginal mass in a child — this must be performed at a specialist centre.

Cystocele (anterior vaginal wall prolapse) is the most common type of pelvic organ prolapse and is frequently under-diagnosed in primary care — it presents as a bulge felt at the vaginal entrance, worse on straining or standing and relieved by lying down. The associated urinary symptoms are clinically important: stress urinary incontinence (the bladder angle is disturbed), urgency and frequency (bladder descent distorts the urethra), difficulty fully emptying the bladder (bladder kinking), and paradoxically — prolapse can sometimes improve stress incontinence by kinking the urethra (creating pseudo-continence that is unmasked after surgical repair). The Pelvic Organ Prolapse Quantification system (POP-Q) provides standardised anatomical description, but in primary care the simplified assessment — stage I (prolapse within vagina), stage II (prolapse to introitus), stage III (prolapse beyond introitus) — is clinically adequate for communication and referral decisions.

The postcoital bleeding assessment is one of the most important GP consultations for early cervical cancer detection — cervical cancer most commonly presents with postcoital bleeding (bleeding after sexual intercourse) because the cancer is at the transformation zone (squamocolumnar junction) and is highly vascular and friable. The GP's role: any woman with postcoital bleeding should have a speculum examination — the cervix must be directly visualised. If the cervix appears normal (smooth, no friable areas, no irregular lesion), the most likely diagnosis is cervical ectopy (columnar epithelium visible on ectocervix — physiological in young women on OCP or in pregnancy), and the management is reassurance or cryotherapy. If the cervix has any irregular, friable, bleeding, or ulcerated area: 2WW colposcopy referral regardless of cervical smear history or HPV status (cervical smears can be falsely negative in invasive carcinoma).

The Gartner duct cyst is a clinical finding that often causes unnecessary patient anxiety when discovered unexpectedly on speculum examination — it is a benign embryological remnant of the mesonephric (Wolffian) duct that persists in some women as a cystic structure in the anterolateral vaginal wall. The clinical features are entirely benign: smooth, thin-walled, 1-4 cm, non-tender, transilluminates, does not change with the menstrual cycle, and has no malignant potential. It may be associated with ipsilateral renal anomalies (embryological — the mesonephric duct also gives rise to the ureteric bud). Management: asymptomatic incidentally-found Gartner cyst = reassure and discharge. No investigation or treatment needed unless symptomatic (dyspareunia) in which case gynaecology referral for aspiration or marsupialisation is appropriate. Documenting the examination finding accurately ('smooth cystic anterolateral vaginal wall mass, likely Gartner duct cyst — no action required') prevents future unnecessary investigation.

The postmenopausal bleeding (PMB) 2WW pathway has a strict zero-tolerance standard — any vaginal bleeding in a postmenopausal woman (defined as no periods for 12 months) must be referred on the 2WW pathway for endometrial cancer exclusion. The exceptions are narrow: if a woman is on sequential HRT (known cyclical withdrawal bleeding) or combined HRT with documented regular spotting that has not changed — but even here, any change in bleeding pattern, unusual timing, or new onset of postmenopausal bleeding requires 2WW referral. The endometrial cancer risk per episode of PMB is approximately 9-10% (higher in women with BMI >30, diabetes, nulliparous, or on tamoxifen). Investigation pathway: transvaginal ultrasound (endometrial thickness ≤4 mm = very low risk; >4 mm = pipelle endometrial biopsy). GPs who manage PMB conservatively without referral, even after a single episode, are taking an indefensible clinical and medicolegal position.

The vaginal mesh controversy has significantly shaped UK pelvic floor surgery since 2018 — the Independent Medicines and Medical Devices Safety Review (Cumberlege Review, 2020) documented significant harm from vaginal mesh complications including chronic pelvic pain, mesh erosion through the vaginal wall, nerve damage, and dyspareunia in tens of thousands of women who had transvaginal mesh procedures for prolapse and stress incontinence. NHS England suspended transvaginal mesh procedures in 2018 pending safety regulation. Key developments: (1) sacrocolpopexy (abdominal/laparoscopic approach) mesh remains available as the standard for apical vault prolapse — this is anatomically and safety-profile distinct from transvaginal mesh; (2) mid-urethral sling (TVT/TOT) for stress urinary incontinence: suspended nationally for new patients since 2019 — currently restricted to specialist mesh centres; (3) any woman with symptoms she believes are related to previous mesh implant should be referred to an NHS Mesh Complication Centre (meshcentres.nhs.uk). GPs must be aware of this issue and not dismiss mesh-related symptoms.

The pyometra (pus-filled uterus) is a diagnosis that GPs must consider in postmenopausal women presenting with unusual vaginal discharge, pelvic pain, or fever — it occurs when cervical stenosis (from cervical cancer, radiotherapy, previous instrumentation, or atrophic postmenopausal changes) prevents drainage of uterine secretions, which then become infected. It can also be the presenting feature of endometrial carcinoma obstructing the cervical canal. Clinical features: elderly postmenopausal woman with offensive vaginal discharge (or no discharge if completely obstructed), lower abdominal pain, fever, and a tender enlarged uterus on bimanual examination. Transvaginal ultrasound shows a fluid-filled uterine cavity. Management: urgent gynaecology referral — cervical dilation for drainage + endometrial sampling (to exclude carcinoma) + IV antibiotics. Approximately 50% of pyometra cases have an underlying endometrial carcinoma.

The NICE guideline on pelvic organ prolapse (NG123, 2019) specifically states that pelvic floor muscle training supervised by a physiotherapist is the first-line treatment for symptomatic pelvic organ prolapse of any stage — including stage II and III prolapse. The clinical evidence base: multiple RCTs (POPPY trial, EXCEL study) demonstrate that a supervised PFMT programme of at least 3 months produces significant improvements in prolapse symptom severity, quality of life, and prolapse stage (approximately 50% of women achieve a one-stage reduction in prolapse severity). The GP referral to a pelvic floor physiotherapist for prolapse should be automatic at the first consultation — it is not appropriate to watchfully wait without physiotherapy input for symptomatic prolapse, regardless of stage. NHS pelvic health physiotherapy services are available in all areas (waiting times vary from weeks to months).

The vaginal pessary removal and reinsertion skills are a core GP competency that is increasingly required in primary care as gynaecology services reduce follow-up appointments — the GP should be trained to: (1) remove a ring pessary (insert fingers into vagina, locate the posterior rim, hook one finger under it and pull forward + down); (2) inspect the vaginal mucosa for any erosion (red raw area) or discharge; (3) clean the pessary with mild soap and water; (4) assess whether it needs upsizing or downsizing (if easily expelled = upsize; if causing discomfort = downsize); and (5) reinsert (fold into half-moon, insert, confirm in correct position — patient should not feel it). GPs without this training should refer patients for hospital or community gynaecology nurse pessary clinics — leaving a ring pessary in situ without checking for more than 6 months risks undetected erosion.